A study of 162,500 patients with uterine cancer found that survival rates varied significantly by race and geographic location, with Black patients experiencing the worst survival outcomes in areas ...

Endometrial cancer doesn't stay silent for long, which is why recognising the red flags early is critical.

A new Viewpoint in eClinicalMedicine argues that immune checkpoint inhibitors have not yet proven they can replace pelvic ...

Adding the PD-1 inhibitor dostarlimab to standard chemotherapy provides sustained survival benefits for patients with deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) advanced ...

The conversation often begins with subtle changes that women might initially dismiss as normal variations in their monthly cycle. Perhaps unusual bleeding between periods, or discharge that seems ...

In January, the American Cancer Society reported that for the first time women younger than 50 had a higher cancer incidence rate than men. Based on 2023 data, cancer incidence rates among women under ...

"If you feel like you need to pee but you can’t, you need to go to the doctor..." ...

Despite initially being told there was nothing wrong, Jo Brown trusted her instinct ...

Is Less More? Maximizing Outcomes by Tailoring Treatments to Patients: Oncofertility and Oncomenopause Doxorubicin plus trabectedin followed by trabectedin maintenance showed a survival advantage over ...

African-American women with uterine cancer have worse survival rates than Caucasian women who received similar treatment even though they had similar prognostic factors, according to a new review of ...